Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105294599B details a novel catalytic asymmetric synthesis for chiral thiadiazine diuretics. This method offers significant supply chain and cost advantages for pharmaceutical manufacturers.
Patent CN101743218B reveals a superior resolution method for trans-2-aminocyclohexanol using 2-methoxyphenylacetic acid, offering high yield and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN111116465B reveals Ag-catalyzed cyanoalkylation. Efficient route for drug intermediates with scalable conditions.
Patent CN113980028A reveals a mild oxidative coupling method for chiral spiro indolones, offering scalable routes for reliable pharmaceutical intermediate suppliers.
Novel nickel-catalyzed carbonylation cyclization for indole compounds. Enhances efficiency and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116640097B enables metal-free sulfur-mediated synthesis offering cost-effective scalable production for high-purity pharmaceutical intermediates globally.
Novel nickel-catalyzed carbonylation using sulfonyl chlorides offers cost reduction in API manufacturing with high purity and scalable processes.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Cost-effective, scalable route for API intermediates without heavy metals.
Advanced metal-free synthesis of 1,2-disubstituted-4-quinolones via Claisen condensation. High yield, mild conditions, cost-effective manufacturing for pharma intermediates.
Novel palladium-catalyzed carbonylation method for indolo[2,1a]isoquinoline. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Patent CN109776546B details a high-yield Re-catalyzed method for indolopyrrolones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN107382782B details a one-step Rh-catalyzed cyclization for high-purity polyaryl naphthol derivatives, offering cost-effective routes for organic photoelectric materials.
Patent CN113072478B details a mild copper-catalyzed N-arylation method using aryl silanes, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN113087667A reveals a green cobalt-catalyzed route for imidazolidinone derivatives using air oxidation, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN114751883B reveals efficient Pd-catalyzed carbonylation for benzofuran-3-carboxamide. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112480015B reveals a one-pot Pd-catalyzed method for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN111662147A reveals a green copper-catalyzed method for diacetylenes, offering cost reduction and scalable manufacturing for pharmaceutical and material science applications.
Advanced synthesis of high-purity DMT-Cl via novel catalytic route. Reduces costs in API manufacturing and ensures supply chain stability for nucleoside production.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity indole-naphthalene intermediates, offering mild conditions and superior enantioselectivity for scalable API production.